|
LM_ID
|
Common Name
|
Systematic Name
|
Species Shorthand
|
Formula
|
Mass
|
|
LMFA01030832
|
28:5(13Z,16Z,19Z,22Z,25Z)
|
13Z,16Z,19Z,22Z,25Z-octacosapentaenoic acid
|
FA 28:5
|
C28H46O2
|
414.349781
|
|
LMFA08020120
|
N-palmitoyl valine
|
N-hexadecanoyl-valine
|
NAVal 16:0
|
C21H41NO3
|
355.308644
|
|
LMFA08020120
|
N-palmitoyl valine
|
N-hexadecanoyl-valine
|
NAVal 16:0
|
C21H41NO3
|
355.308644
|
|
LMFA01030886
|
19:1(9Z)
|
9Z-nonadecenoic acid
|
FA 19:1
|
C19H36O2
|
296.271531
|
|
LMFA03110232
|
5,8-diepi-5-D2t-IsoP
|
(R,E)-5-hydroxy-7-((1R,2R,5S)-5-hydroxy-2-((Z)-oct-2-en-1-yl)-3-oxocyclopentyl)hept-6-enoic acid
|
FA 20:4;O3
|
C20H32O5
|
352.224976
|
|
LMFA04010248
|
10-epi-17-D4t-NeuroP
|
(4Z,7Z)-9-((1R,2R,5S)-5-hydroxy-2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-3-oxocyclopentyl)nona-4,7-dienoic acid
|
FA 22:6;O3
|
C22H32O5
|
376.224976
|
|
LMFA01030874
|
26:1(19Z))
|
19Z-hexacosenoic acid
|
FA 26:1
|
C26H50O2
|
394.381081
|
|
LMFA04010516
|
ent-13-epi-20-J4-NeuroP
|
(4Z,7Z,10Z)-12-((1S,5R)-5-((R,E)-3-hydroxypent-1-en-1-yl)-4-oxocyclopent-2-en-1-yl)dodeca-4,7,10-trienoic acid
|
FA 22:7;O2
|
C22H30O4
|
358.214411
|
|
LMFA04020027
|
(13R,17S,20R)-d14-16-NeuroF[16R,19S]
|
(R,4Z,7Z,10Z,14E)-13-hydroxy-15-((2R,3S,5S)-3-hydroxy-5-((R)-1-hydroxypropyl)tetrahydrofuran-2-yl)pentadeca-4,7,10,14-tetraenoic acid
|
FA 22:5;O4
|
C22H34O6
|
394.235541
|
|
LMFA04020392
|
(10S,13R,16S)-d11-14-NeuroF[14S,17S]
|
(4Z,7Z,10S,11E,13R)-10,13-dihydroxy-13-((2S,4S,5S)-4-hydroxy-5-((Z)-pent-2-en-1-yl)tetrahydrofuran-2-yl)trideca-4,7,11-trienoic acid
|
FA 22:5;O4
|
C22H34O6
|
394.235541
|
|
LMFA04010155
|
ent-7-D4t-NeuroP
|
(R,4Z,8E)-7-hydroxy-9-((1R,2S,5R)-5-hydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)-3-oxocyclopentyl)nona-4,8-dienoic acid
|
FA 22:6;O3
|
C22H32O5
|
376.224976
|
|
LMFA04010265
|
13-epi-20-D4c-NeuroP
|
(4Z,7Z,10Z)-12-((1S,2S,5S)-5-hydroxy-2-((S,E)-3-hydroxypent-1-en-1-yl)-3-oxocyclopentyl)dodeca-4,7,10-trienoic acid
|
FA 22:6;O3
|
C22H32O5
|
376.224976
|
|
LMFA04010334
|
ent-13-E4c-NeuroP
|
(R,4Z,7Z,10Z,14E)-15-((1S,2R,3S)-2-ethyl-3-hydroxy-5-oxocyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid
|
FA 22:6;O3
|
C22H32O5
|
376.224976
|
|
LMFA04010203
|
ent-13-D4t-NeuroP
|
(R,4Z,7Z,10Z,14E)-15-((1R,2S,5R)-2-ethyl-5-hydroxy-3-oxocyclopentyl)-13-hydroxypentadeca-4,7,10,14-tetraenoic acid
|
FA 22:6;O3
|
C22H32O5
|
376.224976
|
|
LMFA04010455
|
20-A4-NeuroP
|
(4Z,7Z,10Z)-12-((1R,2R)-2-((S,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopent-3-en-1-yl)dodeca-4,7,10-trienoic acid
|
FA 22:7;O2
|
C22H30O4
|
358.214411
|
|
LMFA03130123
|
(6S,9R,12R)-d10-5-IsoF[5R,8S]
|
4-((2R,3S,5S)-5-((1R,2Z,4R,6Z)-1,4-dihydroxydodeca-2,6-dien-1-yl)-3-hydroxytetrahydrofuran-2-yl)butanoic acid
|
FA 20:3;O4
|
C20H34O6
|
370.235541
|
|
LMFA02040082
|
(10R,13S,16S)-d14-9-PhytoF[9S,12R]
|
8-((2S,3R,5R)-5-((1S,4S,E)-1,4-dihydroxyhex-2-en-1-yl)-3-hydroxytetrahydrofuran-2-yl)octanoic acid
|
FA 18:2;O4
|
C18H32O6
|
344.219891
|
|
LMFA02040100
|
(10S,13S,16S)-d14-9-PhytoF[9R,12R]
|
8-((2R,3S,5R)-5-((1S,4S,E)-1,4-dihydroxyhex-2-en-1-yl)-3-hydroxytetrahydrofuran-2-yl)octanoic acid
|
FA 18:2;O4
|
C18H32O6
|
344.219891
|
|
LMFA02000080
|
9-HpOME(7E)
|
9-hydroperoxy-7E-octadecenoic acid
|
FA 18:1;O2
|
C18H34O4
|
314.245711
|
|
LMFA02000080
|
9-HpOME(7E)
|
9-hydroperoxy-7E-octadecenoic acid
|
FA 18:1;O2
|
C18H34O4
|
314.245711
|
|
LMFA03130030
|
(5S,9R,12S)-d6-8-IsoF[8s,11R]
|
(S,E)-5-hydroxy-7-((2S,3R,5R)-3-hydroxy-5-((S,Z)-1-hydroxynon-3-en-1-yl)tetrahydrofuran-2-yl)hept-6-enoic acid
|
FA 20:3;O4
|
C20H34O6
|
370.235541
|
|
LMFA04010014
|
ent-4-F4c-NeuroP
|
(R,E)-6-((1S,2R,3S,5R)-3,5-dihydroxy-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)-4-hydroxyhex-5-enoic acid
|
FA 22:5;O3
|
C22H34O5
|
378.240626
|
|
LMFA04020328
|
(13S,16R,19S)-d14-17-NeuroF[17b,20b]
|
(4Z,7Z,10Z,13S,14E,16R)-16-((2S,4S,5S)-5-ethyl-4-hydroxytetrahydrofuran-2-yl)-13,16-dihydroxyhexadeca-4,7,10,14-tetraenoic acid
|
FA 22:5;O4
|
C22H34O6
|
394.235541
|
|
LMFA04010446
|
ent-17-A4-NeuroP
|
(4Z,7Z)-9-((1S,2S)-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopent-3-en-1-yl)nona-4,7-dienoic acid
|
FA 22:7;O2
|
C22H30O4
|
358.214411
|
|
LMFA04020445
|
(7R,10S,13S)-d8-11-NeuroF[11R,14R]
|
(4Z,7R,8E,10S)-7,10-dihydroxy-10-((2R,4S,5R)-4-hydroxy-5-((2Z,5Z)-octa-2,5-dien-1-yl)tetrahydrofuran-2-yl)deca-4,8-dienoic acid
|
FA 22:5;O4
|
C22H34O6
|
394.235541
|
|
LMFA03110176
|
8,5-diepi-5-E2t-IsoP
|
(R,E)-5-hydroxy-7-((1R,2R,3R)-3-hydroxy-2-((Z)-oct-2-en-1-yl)-5-oxocyclopentyl)hept-6-enoic acid
|
FA 20:4;O3
|
C20H32O5
|
352.224976
|
|
LMFA04010036
|
ent-7,10-diepi-4-Fc-NeuroP
|
(S,4Z,8E)-9-((1R,2R,3S,5R)-3,5-dihydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)cyclopentyl)-7-hydroxynona-4,8-dienoic acid
|
FA 22:5;O3
|
C22H34O5
|
378.240626
|
|
LMFA03130197
|
(8S,11S,15S)-d13-9-IsoF[9R,12R]
|
(S,Z)-8-hydroxy-8-((2R,4S,5R)-4-hydroxy-5-((S,E)-3-hydroxyoct-1-en-1-yl)tetrahydrofuran-2-yl)oct-5-enoic acid
|
FA 20:3;O4
|
C20H34O6
|
370.235541
|
|
LMFA04020192
|
(7R,11S,14S)-d8-10-NeuroF[10R,13R]
|
(R,4Z,8E)-7-hydroxy-9-((2R,3S,5R)-3-hydroxy-5-((S,3Z,6Z)-1-hydroxynona-3,6-dien-1-yl)tetrahydrofuran-2-yl)nona-4,8-dienoic acid
|
FA 22:5;O4
|
C22H34O6
|
394.235541
|
|
LMFA04020130
|
(10S,14R,17R)-d11-13-NeuroF[13S,16R]
|
(S,4Z,7Z,11E)-10-hydroxy-12-((2S,3R,5R)-3-hydroxy-5-((R,Z)-1-hydroxyhex-3-en-1-yl)tetrahydrofuran-2-yl)dodeca-4,7,11-trienoic acid
|
FA 22:5;O4
|
C22H34O6
|
394.235541
|
|
LMFA04020444
|
(7R,10S,13R)-d8-11-NeuroF[11S,14S]
|
(4Z,7R,8E,10S)-7,10-dihydroxy-10-((2S,4R,5S)-4-hydroxy-5-((2Z,5Z)-octa-2,5-dien-1-yl)tetrahydrofuran-2-yl)deca-4,8-dienoic acid
|
FA 22:5;O4
|
C22H34O6
|
394.235541
|
|
LMFA04020505
|
(4R,7S,10R)-d5-8-NeuroF[8R,11R]
|
(4R,7S,E)-4,7-dihydroxy-7-((2R,4R,5R)-4-hydroxy-5-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)tetrahydrofuran-2-yl)hept-5-enoic acid
|
FA 22:5;O4
|
C22H34O6
|
394.235541
|
|
LMFA03110221
|
11-epi-8-D2c-IsoP
|
(S,5Z,9E)-8-hydroxy-10-((1S,2S,5S)-5-hydroxy-3-oxo-2-pentylcyclopentyl)deca-5,9-dienoic acid
|
FA 20:4;O3
|
C20H32O5
|
352.224976
|
|
LMFA11000473
|
6,9-Pentacosadiene
|
6,9-Pentacosadiene
|
|
C25H48
|
348.375601
|
|
LMFA12000027
|
3-Methylpentan-2-one
|
3-Methylpentan-2-one
|
|
C6H12O
|
100.088815
|
|
LMFA03110248
|
12-A2-IsoP
|
4-((1R,2R)-2-((S,1E,5Z)-3-hydroxyundeca-1,5-dien-1-yl)-5-oxocyclopent-3-en-1-yl)butanoic acid
|
FA 20:5;O2
|
C20H30O4
|
334.214411
|
|
LMFA12000020
|
3-Hydroxybutan-2-one
|
3-Hydroxybutan-2-one
|
|
C4H8O2
|
88.052430
|
|
LMFA04010361
|
7-epi-14-E4c-NeuroP
|
(Z)-6-((1S,2S,3R)-3-hydroxy-2-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-5-oxocyclopentyl)hex-4-enoic acid
|
FA 22:6;O3
|
C22H32O5
|
376.224976
|
|
LMFA04020448
|
(7R,10S,13S)-d8-11-NeuroF[11S,14S]
|
(4Z,7R,8E,10S)-7,10-dihydroxy-10-((2S,4S,5S)-4-hydroxy-5-((2Z,5Z)-octa-2,5-dien-1-yl)tetrahydrofuran-2-yl)deca-4,8-dienoic acid
|
FA 22:5;O4
|
C22H34O6
|
394.235541
|
|
LMFA03110211
|
11-epi-8-E2t-IsoP
|
(S,5Z,9E)-8-hydroxy-10-((1R,2R,3R)-3-hydroxy-5-oxo-2-pentylcyclopentyl)deca-5,9-dienoic acid
|
FA 20:4;O3
|
C20H32O5
|
352.224976
|
|
LMFA03110266
|
8-A2-IsoP
|
(S,5Z,9E)-8-hydroxy-10-((1R,5R)-2-oxo-5-pentylcyclopent-3-en-1-yl)deca-5,9-dienoic acid
|
FA 20:5;O2
|
C20H30O4
|
334.214411
|
|
LMFA04010273
|
4,7-diepi-4-E4c-NeuroP
|
(R,E)-4-hydroxy-6-((1S,2S,3R)-3-hydroxy-5-oxo-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)hex-5-enoic acid
|
FA 22:6;O3
|
C22H32O5
|
376.224976
|
|
LMFA04010164
|
ent-7,10-diepi-7-D4c-NeuroP
|
(S,4Z,8E)-7-hydroxy-9-((1R,2R,5R)-5-hydroxy-2-((2Z,5Z)-octa-2,5-dien-1-yl)-3-oxocyclopentyl)nona-4,8-dienoic acid
|
FA 22:6;O3
|
C22H32O5
|
376.224976
|
|
LMFA03130064
|
(9S,12R,15S)-d13-8-IsoF[8R,11R]
|
(Z)-7-((2R,3S,5R)-5-((1R,4S,E)-1,4-dihydroxynon-2-en-1-yl)-3-hydroxytetrahydrofuran-2-yl)hept-5-enoic acid
|
FA 20:3;O4
|
C20H34O6
|
370.235541
|
|
LMFA04020042
|
(13S,17S,20R)-d14-16-NeuroF[16S,19R]
|
(S,4Z,7Z,10Z,14E)-13-hydroxy-15-((2S,3S,5R)-3-hydroxy-5-((R)-1-hydroxypropyl)tetrahydrofuran-2-yl)pentadeca-4,7,10,14-tetraenoic acid
|
FA 22:5;O4
|
C22H34O6
|
394.235541
|
|
LMFA04020107
|
(10S,13S,17R)-d15-11-NeuroF[11S,14R]
|
(S,4Z,7Z)-10-hydroxy-10-((2S,4S,5R)-4-hydroxy-5-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)tetrahydrofuran-2-yl)deca-4,7-dienoic acid
|
FA 22:5;O4
|
C22H34O6
|
394.235541
|
|
LMFA04020501
|
(4R,7R,10S)-d5-8-NeuroF[8R,11R]
|
(4R,7R,E)-4,7-dihydroxy-7-((2R,4S,5R)-4-hydroxy-5-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)tetrahydrofuran-2-yl)hept-5-enoic acid
|
FA 22:5;O4
|
C22H34O6
|
394.235541
|
|
LMFA04020395
|
(10S,13S,16R)-d11-14-NeuroF[14S,17R]
|
(4Z,7Z,10S,11E,13S)-10,13-dihydroxy-13-((2S,4R,5R)-4-hydroxy-5-((Z)-pent-2-en-1-yl)tetrahydrofuran-2-yl)trideca-4,7,11-trienoic acid
|
FA 22:5;O4
|
C22H34O6
|
394.235541
|
|
LMFA03110209
|
ent-8-epi-8-E2t-IsoP
|
(S,5Z,9E)-8-hydroxy-10-((1R,2S,3S)-3-hydroxy-5-oxo-2-pentylcyclopentyl)deca-5,9-dienoic acid
|
FA 20:4;O3
|
C20H32O5
|
352.224976
|
|
LMFA11000525
|
8,11-Nonadecadiene
|
8,11-Nonadecadiene
|
|
C19H36
|
264.281701
|